A South Korean survey found future willingness to use GLP-1 weight-loss drugs exceeded reported prescriptions or use in the previous year, placing stated interest ahead of recent experience.
The Korea Herald attributed the results to the 2026 Korea Wellness Report from KB Financial Group Research Institute. The survey included 2,000 adults ages 25 to 69. Overall, 10.3% reported that they had been prescribed a GLP-1 medicine or had used one in the year before the survey.
By contrast, 33.9% of participants indicated willingness to use one in the future. For Gen Z, the corresponding figure reached 39.7%.
Past-year experience differed across generations: 2.9% among baby boomers and 7.7% for Gen X, compared with 14.2% for millennials and 16.5% for Gen Z.
Men reported a higher past-year rate than women, at 11.6% and 9%, respectively. Awareness was greater among women: 83.1% had heard of the drugs, compared with 73% of men.
Continuing use was the stated plan for 65.5% of respondents with prior experience, The Korea Herald reported.
